Advertisement

Douleur et Analgésie

, Volume 27, Issue 3, pp 145–148 | Cite as

L’anesthésie sans opiacés : anecdote ou nécessité ?

  • M. De KockEmail author
Article de Synthèse / Review Article
  • 196 Downloads

Résumé

Ce travail a pour but de remettre en question l’usage systématique de hautes doses d’opiacés synthétiques pendant l’anesthésie. Pour ce faire, les raisons qui ont conduit à cet usage seront discutées. L’origine de l’hyperalgésie et des interactions immunitaires provoquées par ces substances sera présentée. Cela en évoquant des éléments de biologie comparative et les principes de fonctionnement des perceptions sensorielles.

Mots clés

Anesthésie Opiacés Hyperalgésie 

Opiate-free anaesthesia: Anecdotal or a necessity?

Abstract

The aim of this study is to question the systematic use of high-dose synthetic opiates in anaesthesia. In order to do this, the reasons that have led to this use will be discussed. The origin of hyperalgesia and immune interactions caused by these substances will be presented. This will be done by referring to elements of comparative biology and principles of the function of sensory perception.

Keywords

Anaesthesia Opiates Hyperalgesia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Guignard B, Bossard AE, Coste C, et al (2000) Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93:409–17PubMedCrossRefGoogle Scholar
  2. 2.
    Célèrier E, Rivat C, Jun Y, et al (2000) Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92:465–72PubMedCrossRefGoogle Scholar
  3. 3.
    Gerbershagen H, Aduckathil S, van Wijck A, et al (2013) Pain Intensity on the first day after surgery: a prospective cohort study comparing 179 surgical procedures. Anesthesiology 118:933–44CrossRefGoogle Scholar
  4. 4.
    Wu CL, Raja SN (2011) Treatment of acute postoperative pain. Lancet 377:2215–25PubMedCrossRefGoogle Scholar
  5. 5.
    Durieux ME, Tiouririne M (2014) Anesthesia and cancer recurrence: is the balance of evidence shifting? Reg Anesth Pain Med 39:177–8PubMedCrossRefGoogle Scholar
  6. 6.
    Sacerdote P (2006) Opioids and the immune system. Palliat Med 20:s9–s15PubMedGoogle Scholar
  7. 7.
    Mundeleer P, de Castro G (1963) Neuroleptanalgesia: reflexions after 4 years use. Acta Anaesthesiol Belgica 14:96–104Google Scholar
  8. 8.
    Lowenstein E, Hallowell P, Levine FH, et al (1969) Cardiovascular response to large doses of intravenous morphine in man. New Engl J Med 281:1389–93PubMedCrossRefGoogle Scholar
  9. 9.
    Laudenbach V, Calo G, Guerrini R, et al (2001) Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J Clin Invest 107:457–66PubMedCrossRefPubMedCentralGoogle Scholar
  10. 10.
    Aubrun F, Valade N, Coriat P, Riou B (2008) Predictive factors of severe postoperative pain in the postanesthesia care unit. Anesth Analg 106:1535–41PubMedCrossRefGoogle Scholar
  11. 11.
    Collard V, Mistraletti G, Taqi A, et al (2007) Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy. Anesth Analg 105:1255–62PubMedCrossRefGoogle Scholar
  12. 12.
    Wybran J (1985) Enkephalins and endorphins: activation molecules for the immune system and natural killer activity? Neuropeptides 5:371–4PubMedCrossRefGoogle Scholar
  13. 13.
    Mathew B, Lennon FE, Siegler J, et al (2011) The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 112:558–67PubMedCrossRefGoogle Scholar
  14. 14.
    Govitrapong P, Suttitum T, Kotchabhakdi N, Uneklabh T (1998) Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther 286:883–9PubMedGoogle Scholar
  15. 15.
    Tasiemski A, Verger-Bocquet M, Cadet M, et al (2000) Proenkephalin A-derived peptides in invertebrate innate immune process. Mol Brain Res 76:237–52PubMedCrossRefGoogle Scholar
  16. 16.
    Stefano GB, Fricchione G, Goumon Y, Esch T (2005) Pain, immunity, opiate and opioid compounds and health. Med Sci Monit 11:MS47–53Google Scholar
  17. 17.
    Tasiemski A, Salzet M, Benson H, et al (2000) The presence of antibacterial and opioid peptides in human plasma during coronary artery bypass surgery. J Neuroimunol 109:228–35CrossRefGoogle Scholar
  18. 18.
    Stefano GB (1992) Invertebrate and vertebrate neuroimmune and autoimmunoregulatory commonalties involving opioid peptides. Cell Mol Neurobiol 12:357–66PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2014

Authors and Affiliations

  1. 1.Service d’anesthésie-réanimation, cliniques universitaires Saint-Lucuniversité catholique de LouvainBruxellesBelgique

Personalised recommendations